Literature DB >> 31584559

FLAT IRREGULAR PIGMENT EPITHELIUM DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: A Form of Pachychoroid Neovasculopathy?

Hyeseong Hwang1, Jin Young Kim2, Kyung Tae Kim1,3, Ju Byung Chae1, Dong Yoon Kim1.   

Abstract

PURPOSE: To investigate the differences in natural course, intravitreal bevacizumab injection (IVB) responsiveness, and optical coherence tomography angiography findings according to the type of pigment epithelial detachment (PED) in patients with central serous chorioretinopathy (CSC).
METHODS: A retrospective review of angiographically proven CSC patients was conducted. Pigment epithelium detachment was classified as flat irregular or focal. To identify the natural course of CSC, we had observed whether subretinal fluid was improved without any treatment until symptom duration was >3 months. When CSC symptom duration was >3 months, IVB injection was performed. Symptom duration, central subfield thickness, subfoveal choroidal thickness, presence of subretinal fluid, natural course, optical coherence tomography angiography findings, and IVB responsiveness were compared between the PED types.
RESULTS: One hundred eyes were included (64 flat irregular PED vs. 34 focal PED). Flat irregular PED had a longer symptom duration than focal PED (7.20 ± 11.52 vs. 3.69 ± 3.98 months, P = 0.03). In untreated cases, the rate of complete resolution of subretinal fluid was significantly lower in flat irregular PED than in focal PED (34.78% vs. 65.22%, P = 0.017). In contrast to the natural course, responsiveness to IVB was significantly better in flat irregular PED (72.41% vs. 31.58%, P = 0.005). Optical coherence tomography angiography revealed more CNV in flat irregular PED (42.90% vs. 10.00%, P = 0.014). Subfoveal choroidal thickness in flat irregular PED was significantly thicker.
CONCLUSION: In CSC patients with flat irregular PED, the natural course was poor, but treatment response to IVB was favorable. Flat irregular PED patients showed longer symptom duration and thicker subfoveal choroidal thickness than those with focal PED. Optical coherence tomography angiography revealed more choroidal neovascularization in flat irregular PED. These findings suggest that CSC with flat irregular PED could be considered a form of pachychoroid neovasculopathy.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31584559     DOI: 10.1097/IAE.0000000000002662

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  8 in total

1.  Risk factors of persistent subretinal fluid after half-dose photodynamic therapy for treatment-naïve central serous chorioretinopathy.

Authors:  Mengyang Li; Jinfeng Qu; Zhiqiao Liang; Jiyang Tang; Jie Hu; Yuou Yao; Enzhong Jin; Xiaoxin Li; Mingwei Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-13       Impact factor: 3.117

2.  Visualization of Type-1 Macular Neovascularization Secondary to Pachychoroid Spectrum Diseases: A Comparative Study for Sensitivity and Specificity of Indocyanine Green Angiography and Optical Coherence Tomography Angiography.

Authors:  Sibel Demirel; Pınar Güran Beğar; Özge Yanık; Figen Batıoğlu; Emin Özmert
Journal:  Diagnostics (Basel)       Date:  2022-06-02

3.  Flat irregular pigment epithelial detachment over time and outcome of different treatment regimens.

Authors:  Nazanin Ebrahimiadib; Mohammadreza Mehrabi Bahar; Hamid Riazi-Esfahani; Elias Khalili Pour; Fariba Ghassemi; Hooshang Faghihi; Ahmad Mirshahi; Ramak Roohipourmoallai; Alireza Lashay; Alireza Mahmoudi; Kaveh Fadakar
Journal:  Sci Rep       Date:  2022-06-24       Impact factor: 4.996

4.  The morphology of choroidal neovascularization in chronic central serous chorioretinopathy presenting with flat, irregular pigment epithelium detachment.

Authors:  Claudio Azzolini; Jennifer Cattaneo; Laura Premoli; Cristian Metrangolo; Maurizio Chiaravalli; Simone Donati
Journal:  Int Ophthalmol       Date:  2021-03-21       Impact factor: 2.031

5.  Multimodal Imaging in the Management of Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy.

Authors:  Ahmed M Hagag; Shruti Chandra; Hagar Khalid; Ali Lamin; Pearse A Keane; Andrew J Lotery; Sobha Sivaprasad
Journal:  J Clin Med       Date:  2020-06-21       Impact factor: 4.241

6.  InCASEOf scoring system for distinction between pachychoroid-associated macular neovascularization and neovascular age-related macular degeneration in patients older than 50 years.

Authors:  Grazia M Cozzupoli; Enrico Borrelli; Vittorio Capuano; Riccardo Sacconi; Polina Astroz; Marco Battista; Francesco Bandello; Eric Souied; Giuseppe Querques
Journal:  Sci Rep       Date:  2022-02-21       Impact factor: 4.379

7.  Fundus Autofluorescence and Optical Coherence Tomography Characteristics in Different Stages of Central Serous Chorioretinopathy.

Authors:  Mary Ho; Stephanie H W Kwok; Andrew C Y Mak; Frank H P Lai; Danny S C Ng; Li Jia Chen; Lawrence P Iu; Alvin L Young; Marten Brelen
Journal:  J Ophthalmol       Date:  2021-05-31       Impact factor: 1.909

Review 8.  Applications of Multimodal Imaging in Central Serous Chorioretinopathy Evaluation.

Authors:  Mary Ho; Gabriel Li; Andrew Mak; Danny Ng; Lawrence Iu; Frank Lai
Journal:  J Ophthalmol       Date:  2021-07-24       Impact factor: 1.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.